Brown Courtney, Ray Anisa
Novant Health, Winston-Salem, NC 27106, USA; Department of Academic Nursing, Wake Forest School of Medicine, Winston-Salem, NC 27101, USA.
Emergency Room, Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA.
Nurs Clin North Am. 2023 Jun;58(2):165-181. doi: 10.1016/j.cnur.2023.02.009.
In the United States, the opioid epidemic and COVID-19-related substance use have exacerbated the overall incidence of substance use disorders (SUDs). Medication-assisted therapy (MAT), or cognitive and behavioral therapy that combines medications that reduce substance use or acute withdrawal symptoms, has dramatically improved outcomes for SUD patients, including preventing mortality. With recent US Congressional funding for MAT, patients presenting for acute care on MAT-related medications will continue to increase. Nurses should be aware of these medications' mechanism of action, typical side effects, and implications on treating acute pain to optimize their care.
在美国,阿片类药物流行和与新冠疫情相关的物质使用加剧了物质使用障碍(SUDs)的总体发病率。药物辅助治疗(MAT),即结合使用减少物质使用或急性戒断症状的药物的认知行为疗法,显著改善了SUD患者的治疗效果,包括预防死亡。随着美国国会最近为MAT提供资金,因与MAT相关药物前来接受急症护理的患者数量将持续增加。护士应了解这些药物的作用机制、典型副作用以及对治疗急性疼痛的影响,以优化护理。